As nation’s leading manufacturer of autogenous biologics, Newport Laboratories offers solutions where commercial biologics fall short. Autogenous products are designed to address diseases or disease strains for which there is not a commercial option, or where the commercial product is not effective.
Newport Laboratories utilizes cutting-edge PINPOINT Technology to create autogenous vaccines targeting the specific needs of a herd or region. From the latest in isolate analysis and selection techniques to our proprietary manufacturing and adjuventing techniques, Newport’s biologicals are the epitome of today’s science-based autogenous approach.
Focus antigens include:
- Bibersteinia trehalosi
- BVD Type 1b
- Clostridium perfringens Type A
- E. coli
- Histophilus somni
- Mannheimia haemolytica
- Mycoplasma bovis
We are able to build combination products containing any or all of these antigens to best meet your specific needs.